Richard A. Fair - Aug 16, 2021 Form 4/A - Amendment Insider Report for BELLICUM PHARMACEUTICALS, INC (BLCM)

Role
President and CEO, Director
Signature
/s/ Richard A. Fair
Stock symbol
BLCM
Transactions as of
Aug 16, 2021
Transactions value $
$0
Form type
4/A - Amendment
Date filed
8/18/2021, 12:21 PM
Date Of Original Report
Aug 16, 2021
Previous filing
Jun 11, 2021
Next filing
Aug 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLCM Stock Option (right to buy) Award $0 +265K $0.00 265K Aug 16, 2021 Common Stock 265K $2.88 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is being filed to correct the typographical error in the exercise price of the stock option on the original Form 4 filed with the SEC on August 16, 2021